This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Robert Wah, CSC's Chief Medical Officer, Elected AMA President (Photo: Business Wire)

The American Medical Association, the largest physician organization in the U.S., has elected Robert Wah, CSC’s chief medical officer, as its president-elect. His one-year term as president will begin in June 2014, and he will remain CSC’s chief medical officer.
Robert Wah, CSC's chief medical officer, elected AMA President (Photo: Business Wire)

Robert Wah, CSC's chief medical officer, elected AMA President (Photo: Business Wire)

“Robert assumes this important leadership role just as the implementation of the Accountable Care Act begins next year, and he will be at the center of that activity as he works with leaders in healthcare across the U.S. and the world,” noted Andrea Fiumicelli, CSC’s vice president for the healthcare industry. “Through his role with the AMA, Robert will be able to bring back to CSC and its clients deeper insights into healthcare trends, issues and solutions.”

Dr. Wah provides vision and leadership for CSC's team of medically qualified professionals. His expertise contributes to the company’s focus on helping healthcare and life sciences organizations transform their operations using next-generation technology solutions and services.

About CSC

For more information, please visit CSC’s company profile.

Click here to subscribe to Mobile Alerts for CSC.

Photos/Multimedia Gallery Available:
Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community


Chart of I:DJI
DOW 16,374.76 +23.38 0.14%
S&P 500 1,951.13 +2.27 0.12%
NASDAQ 4,733.4970 -16.4820 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs